Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T16:42:00.882Z.
Consensus retrieved: 2026-10-06T11:18:24.262Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T16:42:00.882Z.
Quote observation: 2026-10-06T16:40:25.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a99f3f088f54f9f9c0225e5104dac3e52b54f392bb47ad8d1f9af79329b73e7d
Forward PE Ratio (N/A) = Dated Quote Price ($40.20) / Consensus Forward EPS ($-2.05)
FORWARD PE RATIO
N/A
Edgewise Therapeutics, Inc.
Market Cap
$4.33B
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Edgewise Therapeutics, Inc. (EWTX) | $4.33B | N/A |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.41B | N/A |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.41B | 8.38 |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.43B | N/A |
| LivaNova PLC (LIVN)vs › | $4.15B | 17.35 |
| Relay Therapeutics, Inc. (RLAY)vs › | $4.07B | N/A |
| AbCellera Biologics Inc. (ABCL)vs › | $4.07B | N/A |
| BillionToOne, Inc. (BLLN)vs › | $4.56B | 124.89 |
| ICU Medical, Inc. (ICUI)vs › | $3.97B | N/A |
| Option Care Health, Inc. (OPCH)vs › | $4.66B | 16.53 |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $40.20, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-2.05 | $-2.21 – $-1.96 | 8 | n/m |
| 2027-12-31 | $-1.64 | $-2.29 – $-0.43 | 9 | n/m |
| 2028-12-31 | $-1.86 | $-2.54 – $-1.11 | 8 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
